VERIGRAFT is developing breakthrough tissue therapies and is one of the founding partners of CCRM Nordic, a non-for-profit organisation providing an infrastructure for Nordic stakeholders in advanced therapies.
The two institutions recently had a half-day meeting, identified several synergistic opportunities and as a result agreed to initiate a closer collaboration to prepare for the future in this rapidly growing area. CCRM Nordic will be the ideal partner for VERIGRAFT´s high ambitions and will provide the necessary infrastructure for coming preclinical and clinical development of the company´s platform portfolio.